JOINT FILING AGREEMENTJoint Filing Agreement • July 24th, 2006 • ConPharm • Biological products, (no disgnostic substances)
The undersigned hereby agree that (1) the Statement on Schedule 13D, dated July 24, 2006 ("Schedule 13D"), with respect to the Common Shares of Lorus Therapeutics Inc. is, and any subsequent amendment to the Schedule 13D executed by us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and (2) this agreement shall be included as an exhibit to the Schedule 13D and each such amendment thereto. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
EXHIBIT 2 SHARE PURCHASE AGREEMENT dated as of July 13, 2006Share Purchase Agreement • July 24th, 2006 • ConPharm • Biological products, (no disgnostic substances) • Ontario
